Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Robbert Van Der Voort"'
Publikováno v:
Exploration of Medicine, Vol 2, Iss 2, Pp 167-185 (2021)
The limitations of current cancer treatments have stimulated the application of nanotechnology to develop more effective and safer cancer therapies. Remarkable progress has been made in the development of nanomedicine to overcome issues associated wi
Externí odkaz:
https://doaj.org/article/994d701ee55a43b3921a2beea57f3fd6
Autor:
Harry Dolstra, Robbert van der Voort, Theo M. de Witte, Nicolaas Schaap, J.H. Frederik Falkenburg, Konnie Hebeda, Michel G.D. Kester, Michael Quigley, Alan Korman, Willemijn Hobo, Frans Maas, Wieger J. Norde
Supplementary Figure 2 from PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5869322add589cc23826e5cbc9cef3f5
https://doi.org/10.1158/0008-5472.22389062
https://doi.org/10.1158/0008-5472.22389062
Autor:
Harry Dolstra, Robbert van der Voort, Theo M. de Witte, Nicolaas Schaap, J.H. Frederik Falkenburg, Konnie Hebeda, Michel G.D. Kester, Michael Quigley, Alan Korman, Willemijn Hobo, Frans Maas, Wieger J. Norde
Supplementary Figure 1 from PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0588e81c81f6fc110d8da7e04603292e
https://doi.org/10.1158/0008-5472.22389065.v1
https://doi.org/10.1158/0008-5472.22389065.v1
Autor:
Geert D’Haens, Florian Rieder, Brian G. Feagan, Peter D.R. Higgins, Julian Panés, Christian Maaser, Gerhard Rogler, Mark Löwenberg, Robbert van der Voort, Massimo Pinzani, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca, Gert De Hertogh, Chris Denton, Jörg Distler, Kelly McCarrier, Dermot McGovern, Tim Radstake, Daniel Serrano, Jaap Stoker
Publikováno v:
Gastroenterology
Gastroenterology, 162(1), 26-31. W.B. Saunders Ltd
Gastroenterology, 162(1), 26-31. W.B. Saunders Ltd
Intestinal fibrosis is a common complication of inflammatory bowel disease (IBD) that is usually the consequence of chronic inflammation. Although the currently available anti-inflammatory therapies have had little impact on intestinal fibrosis in Cr
Publikováno v:
Exploration of Medicine, Vol 2, Iss 2, Pp 167-185 (2021)
The limitations of current cancer treatments have stimulated the application of nanotechnology to develop more effective and safer cancer therapies. Remarkable progress has been made in the development of nanomedicine to overcome issues associated wi
Autor:
Jeannette Cany, Anniek B van der Waart, Marleen Tordoir, Gerben M Franssen, Basav N Hangalapura, Jolanda de Vries, Otto Boerman, Nicolaas Schaap, Robbert van der Voort, Jan Spanholtz, Harry Dolstra
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e64384 (2013)
Natural killer (NK) cell-based adoptive immunotherapy is an attractive adjuvant treatment option for patients with acute myeloid leukemia. Recently, we reported a clinical-grade, cytokine-based culture method for the generation of NK cells from umbil
Externí odkaz:
https://doaj.org/article/c2e6601803c9446fb2f2ad14ce819f13
Autor:
Anniek B van der Waart, Walter J F M van der Velden, Astrid G S van Halteren, Marij J L G Leenders, Ton Feuth, Nicole M A Blijlevens, Robbert van der Voort, Harry Dolstra
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50896 (2012)
The C-type lectin-like receptor CD161 is a well-established marker for human IL17-producing T cells, which have been implicated to contribute to the development of graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (allo-SCT)
Externí odkaz:
https://doaj.org/article/53608eff28044222abd541c81e72cd5c
Autor:
Sulima Geerman, Jaap D. van Buul, Mark Hoogenboezem, Stephanie Gessel, Marieke Goedhart, Beth Lucas, Graham Anderson, Martijn A. Nolte, Carlijn Voermans, Timo Rademakers, Ellis Gielen, Stephan Huveneers, Robbert van der Voort, Harry Dolstra, Edith Slot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dc1684836e3a1f2b44608bb72e91df5
https://doi.org/10.1002/eji.201747438/v4/response1
https://doi.org/10.1002/eji.201747438/v4/response1
Autor:
Graham Anderson, Mark Hoogenboezem, Edith Slot, Martijn A. Nolte, Marieke Goedhart, Stephanie Gessel, Carlijn Voermans, Jaap D. van Buul, Ellis Gielen, Sulima Geerman, Beth Lucas, Stephan Huveneers, Robbert van der Voort, Timo Rademakers, Harry Dolstra
Publikováno v:
European Journal of Immunology, 49, 576-589
European Journal of Immunology, 49(4), 576-589. Wiley
European Journal of Immunology, 49, 4, pp. 576-589
European journal of immunology, 49(4), 576-589. Wiley-VCH Verlag
European Journal of Immunology, 49(4), 576-589. Wiley
European Journal of Immunology, 49, 4, pp. 576-589
European journal of immunology, 49(4), 576-589. Wiley-VCH Verlag
The BM serves as a blood-forming organ, but also supports the maintenance and immune surveillance function of many T cells. Yet, in contrast to other organs, little is known about the molecular mechanisms that drive T-cell migration to and localizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c6c2ad0556ccb1bf9f7414c24b7fbf
http://hdl.handle.net/2066/202774
http://hdl.handle.net/2066/202774
Autor:
Marieke, Goedhart, Stephanie, Gessel, Robbert, van der Voort, Edith, Slot, Beth, Lucas, Ellis, Gielen, Mark, Hoogenboezem, Timo, Rademakers, Sulima, Geerman, Jaap D, van Buul, Stephan, Huveneers, Harry, Dolstra, Graham, Anderson, Carlijn, Voermans, Martijn A, Nolte
Publikováno v:
European journal of immunology. 49(4)
The BM serves as a blood-forming organ, but also supports the maintenance and immune surveillance function of many T cells. Yet, in contrast to other organs, little is known about the molecular mechanisms that drive T-cell migration to and localizati